Loading clinical trials...
Loading clinical trials...
Changes in Bile Acid Profile and Gut Microbiota in Patients Undergoing Treatment With Bulevirtide for Hepatitis Delta Virus Infection
Conditions
Locations
1
Italy
Fondazione Policlinico Universitaro A. Gemelli IRCSS UOC CEMAD
Roma, Italy
Start Date
September 24, 2025
Primary Completion Date
October 1, 2027
Completion Date
October 1, 2027
Last Updated
February 24, 2026
NCT07265544
NCT04378439
NCT06953479
NCT05653232
NCT06671093
NCT07275554
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions